Nutex Health Extends Stock Repurchase Program to Enhance Shareholder Value

Nutex Health Expands Shareholder Value Initiatives with Stock Repurchase Program Extension

Nutex Health Inc., a Houston-based integrated healthcare delivery system, announces a significant extension of its stock repurchase program, initially designed to enhance shareholder value. The program, originally set to repurchase up to $25 million of common stock over six months following the filing of its Form 10-Q for the quarter ending June 30, 2025, is now extended through March 31, 2026. This strategic move aims to mitigate dilution resulting from stock compensation tied to the ongoing construction and operational ramp-up of new micro hospitals across the United States.

The decision to extend the buyback program underscores Nutex's commitment to long-term shareholder value and reflects the Board’s confidence in the company's growth trajectory. The repurchase will be conducted in accordance with Rule 10b-18 under the Securities Exchange Act of 1934 and will utilize a Rule 10b5-1 trading plan, set to become effective around December 4, 2025. By executing this program, Nutex aims to optimize its capital structure while ensuring that any repurchases will be executed at the company’s discretion, taking into account market conditions and overall company performance.

Nutex Health operates a network of 25 state-of-the-art micro hospitals and outpatient departments across 11 states, focusing on innovative healthcare delivery models. The company consists of two primary divisions: the Hospital Division, which is responsible for developing and managing these healthcare facilities, and the Population Health Management Division, which oversees a risk-bearing physician network dedicated to primary care. The Board’s flexibility in amending, suspending, or discontinuing the repurchase program further indicates Nutex’s adaptive financial strategy in response to changing market dynamics.

In addition to the share repurchase program, Nutex Health demonstrates its commitment to advancing healthcare delivery through its innovative hospital models. The company's focus on integrating healthcare services positions it well within the evolving landscape of the healthcare industry, where efficiency and patient-centered care are paramount.

As Nutex continues to expand its presence in the healthcare sector, the emphasis on shareholder value and operational efficiency remains a key driver of its corporate strategy. The extension of the stock repurchase program not only reinforces investor confidence but also aligns with Nutex’s mission to enhance healthcare access and quality across the communities it serves.